Dry Powder Inhaler Device Market - Global Outlook and Forecast 2022-2028
Report Code: KNJ1144945 No. of Pages: 79 Category: Medical Devices
Publisher: Date of Publish:
Publisher: Date of Publish:
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
This report contains market size and forecasts of Dry Powder Inhaler Device in global, including the following market information:
Global Dry Powder Inhaler Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dry Powder Inhaler Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Dry Powder Inhaler Device companies in 2021 (%)
The global Dry Powder Inhaler Device market was valued at 809.4 million in 2021 and is projected to reach US$ 1115.5 million by 2028, at a CAGR of 4.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Dose Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dry Powder Inhaler Device include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dry Powder Inhaler Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dry Powder Inhaler Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dry Powder Inhaler Device Market Segment Percentages, by Type, 2021 (%)
Single Dose
Multi Dose
Global Dry Powder Inhaler Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dry Powder Inhaler Device Market Segment Percentages, by Application, 2021 (%)
Asthma
COPD
Others
Global Dry Powder Inhaler Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dry Powder Inhaler Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dry Powder Inhaler Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dry Powder Inhaler Device revenues share in global market, 2021 (%)
Key companies Dry Powder Inhaler Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Dry Powder Inhaler Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
1 Introduction to Research & Analysis Reports
1.1 Dry Powder Inhaler Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dry Powder Inhaler Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dry Powder Inhaler Device Overall Market Size
2.1 Global Dry Powder Inhaler Device Market Size: 2021 VS 2028
2.2 Global Dry Powder Inhaler Device Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Dry Powder Inhaler Device Sales: 2017-2028
3 Company Landscape
3.1 Top Dry Powder Inhaler Device Players in Global Market
3.2 Top Global Dry Powder Inhaler Device Companies Ranked by Revenue
3.3 Global Dry Powder Inhaler Device Revenue by Companies
3.4 Global Dry Powder Inhaler Device Sales by Companies
3.5 Global Dry Powder Inhaler Device Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Dry Powder Inhaler Device Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Dry Powder Inhaler Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dry Powder Inhaler Device Players in Global Market
3.8.1 List of Global Tier 1 Dry Powder Inhaler Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Dry Powder Inhaler Device Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Dry Powder Inhaler Device Market Size Markets, 2021 & 2028
4.1.2 Single Dose
4.1.3 Multi Dose
4.2 By Type - Global Dry Powder Inhaler Device Revenue & Forecasts
4.2.1 By Type - Global Dry Powder Inhaler Device Revenue, 2017-2022
4.2.2 By Type - Global Dry Powder Inhaler Device Revenue, 2023-2028
4.2.3 By Type - Global Dry Powder Inhaler Device Revenue Market Share, 2017-2028
4.3 By Type - Global Dry Powder Inhaler Device Sales & Forecasts
4.3.1 By Type - Global Dry Powder Inhaler Device Sales, 2017-2022
4.3.2 By Type - Global Dry Powder Inhaler Device Sales, 2023-2028
4.3.3 By Type - Global Dry Powder Inhaler Device Sales Market Share, 2017-2028
4.4 By Type - Global Dry Powder Inhaler Device Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Dry Powder Inhaler Device Market Size, 2021 & 2028
5.1.2 Asthma
5.1.3 COPD
5.1.4 Others
5.2 By Application - Global Dry Powder Inhaler Device Revenue & Forecasts
5.2.1 By Application - Global Dry Powder Inhaler Device Revenue, 2017-2022
5.2.2 By Application - Global Dry Powder Inhaler Device Revenue, 2023-2028
5.2.3 By Application - Global Dry Powder Inhaler Device Revenue Market Share, 2017-2028
5.3 By Application - Global Dry Powder Inhaler Device Sales & Forecasts
5.3.1 By Application - Global Dry Powder Inhaler Device Sales, 2017-2022
5.3.2 By Application - Global Dry Powder Inhaler Device Sales, 2023-2028
5.3.3 By Application - Global Dry Powder Inhaler Device Sales Market Share, 2017-2028
5.4 By Application - Global Dry Powder Inhaler Device Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Dry Powder Inhaler Device Market Size, 2021 & 2028
6.2 By Region - Global Dry Powder Inhaler Device Revenue & Forecasts
6.2.1 By Region - Global Dry Powder Inhaler Device Revenue, 2017-2022
6.2.2 By Region - Global Dry Powder Inhaler Device Revenue, 2023-2028
6.2.3 By Region - Global Dry Powder Inhaler Device Revenue Market Share, 2017-2028
6.3 By Region - Global Dry Powder Inhaler Device Sales & Forecasts
6.3.1 By Region - Global Dry Powder Inhaler Device Sales, 2017-2022
6.3.2 By Region - Global Dry Powder Inhaler Device Sales, 2023-2028
6.3.3 By Region - Global Dry Powder Inhaler Device Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Dry Powder Inhaler Device Revenue, 2017-2028
6.4.2 By Country - North America Dry Powder Inhaler Device Sales, 2017-2028
6.4.3 US Dry Powder Inhaler Device Market Size, 2017-2028
6.4.4 Canada Dry Powder Inhaler Device Market Size, 2017-2028
6.4.5 Mexico Dry Powder Inhaler Device Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Dry Powder Inhaler Device Revenue, 2017-2028
6.5.2 By Country - Europe Dry Powder Inhaler Device Sales, 2017-2028
6.5.3 Germany Dry Powder Inhaler Device Market Size, 2017-2028
6.5.4 France Dry Powder Inhaler Device Market Size, 2017-2028
6.5.5 U.K. Dry Powder Inhaler Device Market Size, 2017-2028
6.5.6 Italy Dry Powder Inhaler Device Market Size, 2017-2028
6.5.7 Russia Dry Powder Inhaler Device Market Size, 2017-2028
6.5.8 Nordic Countries Dry Powder Inhaler Device Market Size, 2017-2028
6.5.9 Benelux Dry Powder Inhaler Device Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Dry Powder Inhaler Device Revenue, 2017-2028
6.6.2 By Region - Asia Dry Powder Inhaler Device Sales, 2017-2028
6.6.3 China Dry Powder Inhaler Device Market Size, 2017-2028
6.6.4 Japan Dry Powder Inhaler Device Market Size, 2017-2028
6.6.5 South Korea Dry Powder Inhaler Device Market Size, 2017-2028
6.6.6 Southeast Asia Dry Powder Inhaler Device Market Size, 2017-2028
6.6.7 India Dry Powder Inhaler Device Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Dry Powder Inhaler Device Revenue, 2017-2028
6.7.2 By Country - South America Dry Powder Inhaler Device Sales, 2017-2028
6.7.3 Brazil Dry Powder Inhaler Device Market Size, 2017-2028
6.7.4 Argentina Dry Powder Inhaler Device Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Dry Powder Inhaler Device Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Dry Powder Inhaler Device Sales, 2017-2028
6.8.3 Turkey Dry Powder Inhaler Device Market Size, 2017-2028
6.8.4 Israel Dry Powder Inhaler Device Market Size, 2017-2028
6.8.5 Saudi Arabia Dry Powder Inhaler Device Market Size, 2017-2028
6.8.6 UAE Dry Powder Inhaler Device Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Dry Powder Inhaler Device Major Product Offerings
7.1.4 GlaxoSmithKline Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Dry Powder Inhaler Device Major Product Offerings
7.2.4 AstraZeneca Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Major Product Offerings
7.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.3.5 Boehringer Ingelheim Key News
7.4 Chiesi
7.4.1 Chiesi Corporate Summary
7.4.2 Chiesi Business Overview
7.4.3 Chiesi Dry Powder Inhaler Device Major Product Offerings
7.4.4 Chiesi Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.4.5 Chiesi Key News
7.5 Cipla
7.5.1 Cipla Corporate Summary
7.5.2 Cipla Business Overview
7.5.3 Cipla Dry Powder Inhaler Device Major Product Offerings
7.5.4 Cipla Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.5.5 Cipla Key News
7.6 3M
7.6.1 3M Corporate Summary
7.6.2 3M Business Overview
7.6.3 3M Dry Powder Inhaler Device Major Product Offerings
7.6.4 3M Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.6.5 3M Key News
7.7 Hovione
7.7.1 Hovione Corporate Summary
7.7.2 Hovione Business Overview
7.7.3 Hovione Dry Powder Inhaler Device Major Product Offerings
7.7.4 Hovione Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.7.5 Hovione Key News
7.8 Mannkind
7.8.1 Mannkind Corporate Summary
7.8.2 Mannkind Business Overview
7.8.3 Mannkind Dry Powder Inhaler Device Major Product Offerings
7.8.4 Mannkind Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.8.5 Mannkind Key News
7.9 Mylan
7.9.1 Mylan Corporate Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Dry Powder Inhaler Device Major Product Offerings
7.9.4 Mylan Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.9.5 Mylan Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Dry Powder Inhaler Device Major Product Offerings
7.10.4 Novartis Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Schering/Merck
7.11.1 Schering/Merck Corporate Summary
7.11.2 Schering/Merck Dry Powder Inhaler Device Business Overview
7.11.3 Schering/Merck Dry Powder Inhaler Device Major Product Offerings
7.11.4 Schering/Merck Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.11.5 Schering/Merck Key News
7.12 Teva
7.12.1 Teva Corporate Summary
7.12.2 Teva Dry Powder Inhaler Device Business Overview
7.12.3 Teva Dry Powder Inhaler Device Major Product Offerings
7.12.4 Teva Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.12.5 Teva Key News
7.13 Vectura
7.13.1 Vectura Corporate Summary
7.13.2 Vectura Dry Powder Inhaler Device Business Overview
7.13.3 Vectura Dry Powder Inhaler Device Major Product Offerings
7.13.4 Vectura Dry Powder Inhaler Device Sales and Revenue in Global (2017-2022)
7.13.5 Vectura Key News
8 Global Dry Powder Inhaler Device Production Capacity, Analysis
8.1 Global Dry Powder Inhaler Device Production Capacity, 2017-2028
8.2 Dry Powder Inhaler Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Dry Powder Inhaler Device Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dry Powder Inhaler Device Supply Chain Analysis
10.1 Dry Powder Inhaler Device Industry Value Chain
10.2 Dry Powder Inhaler Device Upstream Market
10.3 Dry Powder Inhaler Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dry Powder Inhaler Device Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com